Tag Archives: Takeda

Patients and R&D Leaders Jointly Present at EU Conference on Progress with Patient-Input to Transform Medicine Development

(PRESS RELEASE) New York, NY, United States, 5-Jan-2022 — /EuropaWire/ — The Conference Forum announced the launch of the 6th annual EU Patients as Partners in Medicines Development conference to take place virtually on January 24-25th, 2022 GMT time. ​​This … Read the full press release

H. Lundbeck A/S, Takeda announced that US FDA accepted a supplemental New Drug Application (sNDA) for review of Brintellix (vortioxetine)

Valby, Denmark and Osaka, Japan, 12-8-2015 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) announced today the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for review to add … Read the full press release